<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02720653</url>
  </required_header>
  <id_info>
    <org_study_id>DC005805-11</org_study_id>
    <nct_id>NCT02720653</nct_id>
  </id_info>
  <brief_title>Determinants of Olfactory Dysfunction in Chronic Rhinosinusitis</brief_title>
  <official_title>Determinants of Olfactory Dysfunction in Chronic Rhinosinusitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Olfactory dysfunction is a cardinal symptom of chronic rhinosinusitis, a disease which&#xD;
      affects 12.5% of the adult population across all racial and ethnic groups. Previous research&#xD;
      has documented olfactory deficit in 68% of patients with chronic rhinosinusitis and 20% with&#xD;
      complete anosmia, suggesting that olfactory dysfunction affects over 25 million individuals&#xD;
      in the United States with chronic rhinosinusitis. This proposed investigation will be used to&#xD;
      predict olfactory outcomes following treatments for chronic rhinosinusitis and gain insights&#xD;
      into mechanisms of olfactory dysfunction in this population.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sniffin' Stick olfactory testing</measure>
    <time_frame>6 months</time_frame>
    <description>Improvement in olfactory function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>22-Item Sinonasal Outcome Test</measure>
    <time_frame>6 months</time_frame>
    <description>Improvement in disease specific quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire for Olfactory Dysfunction, QOD-NS</measure>
    <time_frame>6 months</time_frame>
    <description>Improvement in olfactory specific quality of life</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Chronic Rhinosinusitis</condition>
  <condition>Olfactory Dysfunction</condition>
  <arm_group>
    <arm_group_label>Appropriate Medical Therapy</arm_group_label>
    <description>Patients will self-select continued, non-standardized, appropriate medical management of symptoms associated with chronic sinusitis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endoscopic Sinus Surgery</arm_group_label>
    <description>Patients will self-select endoscopic sinus surgery for symptoms associated with chronic sinusitis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic sinus surgery</intervention_name>
    <arm_group_label>Endoscopic Sinus Surgery</arm_group_label>
    <other_name>Sinus surgery</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Mucus specimens will be collected and analyzed for cytokine profiles and proteomics&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who present in clinic with indications of medically refractory chronic sinusitis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult ( &gt; 18 years of age)&#xD;
&#xD;
          -  A diagnosis of medical recalcitrant CRS as defined by 2015 Adult Sinusitis Guidelines&#xD;
             outlined by the American Academy of Otolaryngology&#xD;
&#xD;
          -  Provide written informed consent and authorization.&#xD;
&#xD;
          -  Study participants must be able to complete consent, all study evaluations, olfactory&#xD;
             testing, and study-related health questionnaires written in the English language.&#xD;
&#xD;
          -  Patients must self-select subsequent treatment option (endoscopic sinus surgery or&#xD;
             continued medical therapy) to be dictated by the disease process and judgment and&#xD;
             preferences of each individual, following counseling for each treatment option.&#xD;
&#xD;
          -  Present to the enrolling site with indication for a CT scan or a CT scan completed,&#xD;
             off-site, from another provider&#xD;
&#xD;
          -  Complete appropriate standardized medical treatment by the Interim Assessment, 6-week&#xD;
             follow-up period including, but not limited to, at least one course of either topical&#xD;
             corticosteroids (&gt;21-days) or a 5-day course of oral corticosteroid therapy, and at&#xD;
             least one course (&gt;14-days) of culture-directed or broad spectrum antibiotic therapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children (&lt; 18 years of age)&#xD;
&#xD;
          -  Any patient unable and/or unwilling to complete questionnaires or clinical testing or&#xD;
             cooperate with all study protocols.&#xD;
&#xD;
          -  Non-English speaking / English translation services required&#xD;
&#xD;
          -  Unwilling or unable to provide informed, written consent.&#xD;
&#xD;
          -  Contra-indications for any type of continued medical therapy required for treatment of&#xD;
             symptoms related to CRS&#xD;
&#xD;
          -  Patients who have not undergone previous prescribed medical therapy as described in&#xD;
             Inclusion Criteria.&#xD;
&#xD;
          -  Individuals of any vulnerable population including: children, pregnant women,&#xD;
             neonates, decisionally impaired adults, or prisoners.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 22, 2016</study_first_submitted>
  <study_first_submitted_qc>March 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2016</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Dr. Timothy L. Smith</investigator_full_name>
    <investigator_title>Professor, Chief of Rhinology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

